Gland Pharma Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GLAND PHARMA LTD, and what generic and branded alternatives to GLAND PHARMA LTD drugs are available?
GLAND PHARMA LTD has one hundred and eighteen approved drugs.
There are two tentative approvals on GLAND PHARMA LTD drugs.
Summary for Gland Pharma Ltd
US Patents: | 0 |
Tradenames: | 108 |
Ingredients: | 103 |
NDAs: | 118 |
Drug Master File Entries: | 37 |
Drugs and US Patents for Gland Pharma Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gland Pharma Ltd | DESMOPRESSIN ACETATE | desmopressin acetate | INJECTABLE;INJECTION | 216922-001 | Nov 16, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Gland Pharma Ltd | ESOMEPRAZOLE SODIUM | esomeprazole sodium | INJECTABLE;INTRAVENOUS | 203349-002 | Apr 1, 2020 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Gland Pharma Ltd | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 210102-002 | Aug 18, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Gland Pharma Ltd | ZINC SULFATE | zinc sulfate | SOLUTION;INTRAVENOUS | 216249-001 | May 3, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Gland Pharma Ltd | THIOTEPA | thiotepa | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | 214222-001 | Mar 8, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Gland Pharma Ltd | EDARAVONE | edaravone | SOLUTION;INTRAVENOUS | 216199-002 | May 6, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Gland Pharma Ltd | PACLITAXEL | paclitaxel | INJECTABLE;INJECTION | 207326-001 | Aug 23, 2016 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for GLAND PHARMA LTD drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 1 mg/mL, 50 mL vials | ➤ Subscribe | 2011-12-16 |
➤ Subscribe | Injection | 100 mg/mL, 2.5 mL vials | ➤ Subscribe | 2007-09-24 |
➤ Subscribe | Injection | 250 mcg/0.5 mL, 1 mL PFS | ➤ Subscribe | 2012-03-30 |
Similar Applicant Names
Here is a list of applicants with similar names.